Cargando…
Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk
BACKGROUND: In cholera epidemics, the spread of disease can easily outpace vaccine control measures. The advent of technologies enabling the expression of recombinant proteins, including antibodies, in the milk of transgenic animals raises the prospect of developing a self-administered and cost-effe...
Autores principales: | Baranova, Danielle E., Chen, Lihow, Destrempes, Margaret, Meade, Harry, Mantis, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pathogens and Immunity
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204294/ https://www.ncbi.nlm.nih.gov/pubmed/34136728 http://dx.doi.org/10.20411/pai.v5i1.370 |
Ejemplares similares
-
The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
por: Richards, Angelene, et al.
Publicado: (2021) -
Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination
por: Baranova, Danielle E., et al.
Publicado: (2018) -
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
por: Richards, Angelene F., et al.
Publicado: (2020) -
Transient Suppression of Shigella flexneri Type 3 Secretion by a Protective O-Antigen-Specific Monoclonal IgA
por: Forbes, Stephen J., et al.
Publicado: (2011) -
Monoclonal IgA Antibodies for Aflatoxin Immunoassays
por: Ertekin, Özlem, et al.
Publicado: (2016)